Empyema following the percutaneous instillation of antifungal agents in patients with aspergillosis

Internal Medicine

Volumn 35, Issue 8, 1996, Pages 657-659

  Nakanishi, Yoichi ^a   Wakamatsu, Kentaro ^a   Nomoto, Yoshitsugu ^a   Kawasaki, Masayuki ^a   Takayama, Koichi ^a   Yatsunami, Jun ^a   Tsuruta, Nobuko ^a   Hashimoto, Shuichi ^a   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

amphotericin B; fluconazole; iatrogenic; local treatment

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

AGED; ARTICLE; ASPERGILLOSIS; CASE REPORT; EMPYEMA; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; PLEURA BIOPSY;

EID: 0029905673     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.657     Document Type: Article

References (9)

1. Glimp RA, Bayer AS. Pulmonary aspergilloma: diagnostic and therapeutic considerations. Arch Intern Med 143: 301, 1983.
2. Hargis JL, Bone RC, Stewart J, Rector N, Hiller FC. Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med 68: 389, 1980.
3. Shapiro MJ, Albelda SM, Mayock RL, McLean GK. Severe hemoptysis associated with pulmonary aspergilloma. Percutaneous intracavitary treatment. Chest 94: 1225, 1988.
4. Yamada H, Kohno S, Koga H, Maesaki S, Kaku M. Topical treatment of pulmonary aspergilloma by antifungals. Chest 103: 1421, 1993.
5. Cochrane LJ, Morano JU, Norman JR, Mansel JK. Use of intracavitary amphotericin B in a patient with aspergilloma and recurrent hemoptysis. Am J Med 90: 654, 1991 (letter).
6. Hillerdal G. Pulmonary aspergillus infection invading the pleura. Thorax 36: 745, 1981.
7. Meredith HC, Corgan BM, McLaulin B. Pleural aspergillosis. AJR Am J Roentgenol 130: 164, 1978.
8. Parry MF, Coughlin FR, Zambetti X. Aspergillus empyema. Chest 81: 768, 1982.
9. Furuse F, Nakanishi Y, Kotoh H, et al. Percutaneous intracavitary treatment of pulmonary aspergilloma - clinical efficacy and prognosis. Jpn J Thorac Dis 32: 538, 1994 (abstract in English).